Dr. Rimner is a radiation oncologist and Scientific Director at the Comprehensive Cancer Center of Freiberg in Baden-Württemberg, Germany. He previously worked with a multidisciplinary team at Memorial Sloan Kettering Cancer Center to identify the best treatment options for patients diagnosed with thoracic cancers. He specializes in a wide range of malignancies, including lung cancer,
Dr. Pennell is a board-certified medical oncologist who has spent more than two decades in clinical practice, specializing in the treatment of thoracic malignancies, including malignant pleural mesothelioma and lung cancer. He now serves as Senior Vice President, Worldwide Head of Medical Affairs, Hematology & Oncology for Bristol Myers Squibb. Prior to this, he was
Dr. Zauderer is a leading expert and researcher specializing in caring for people with thoracic cancers, including malignant pleural mesothelioma. As Professor of Medicine of Westchester Medical Center’s Division of Hematology and Neoplastic Diseases and Medicine in the Division of Oncology, she works with a multidisciplinary team of thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists,
Dr. Prasad S. Adusumilli is a thoracic surgeon and cellular therapist at the renowned Memorial Sloan Kettering Cancer Center. Over a 20-year career, he has specialized in treating patients with lung cancer, malignant pleural mesothelioma, and metastatic cancers to the lung. He sees approximately 600 patients each year, focusing on early diagnosis and accurate staging
Dr. Richard James Battafarano is a thoracic surgeon in Johns Hopkins Department of Surgery. He is both the Director of the Division of General Thoracic Surgery and Johns Hopkins’ first regional director of general thoracic surgery. He has significant skill and experience in conducting complex surgical procedures in the treatment of chest diseases like pleural
Dr. Forde is an internist and oncologist dedicated to treating thoracic cancers like mesothelioma, and researching the impact of immunotherapy in the treatment of lung cancer and mesothelioma. He is currently an Associate Member of the Bloomberg Kimmel Institute for Cancer Immunotherapy and the director of the Thoracic Cancer Clinical Research Program at Johns Hopkins’
Dr. Albelda is one of the world’s most respected experts in the field of thoracic oncology. He is the William Maul Measey Professor of Medicine at the Perelman School of Medicine and Associate Director of the Pulmonary Division, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung
Dr. Keith Cengel is a board-certified radiation oncologist practicing in Philadelphia, Pennsylvania. He is the Executive Director of the Mesothelioma and Pleural Diseases Program and a Penn Medicine physician. As Director of the Photodynamic Therapy Program, he has special expertise in the use of advanced radiation therapy protocols to treat malignant mesothelioma. Education and Career
Dr. Lambright is a general thoracic surgeon with special interests in pulmonary malignancies, including malignant mesothelioma. He has conducted extensive research in novel therapies for chest malignancies, including cancer gene therapies. In addition to his work at Vanderbilt, he is Chief of Thoracic Surgery at Nashville Veterans’ Affairs Hospital. Education and Career Born in Adidome, Ghana,
Unlike the United States, many countries in Europe and across the world have banned the use of asbestos in order to lower the risk of malignant mesothelioma and other asbestos-related diseases. But the continued presence of asbestos in already-built structures continues to pose a threat, and together with the European Parliament, the Council of the